Close Menu

University of Pittsburgh

The University of Pittsburgh will use WaferGen's system for high-throughput gene expression studies.

The $1.4 million grant will support a collaboration to develop sub-cellular tracking and imaging software tools.

University of Pittsburgh School of Medicine researcher Bino John and colleagues reported recently that a so-called unusually small RNA — around 17 nucleotides long — can down-regulate a microRNA target, suggesting a gene-regulation role for the RNA.

GE Healthcare and the University of Pittsburgh Medical Center formed Omnyx last year to improve the speed and efficiency of the diagnosis and interpretation of lab results.

The most recent suit, filed last week, alleges that the researcher misrepresented and falsified data related to prostate cancer biomarkers after Onconome sponsored "millions of dollars" of research at his University of Pittsburgh and Johns Hopkins University labs to see if the technology could lead to a clinical diagnostic test for prostate cancer.

Under the Phenotypic Drug Discovery program, researchers from academia or biotech submit candidate compounds in specific therapeutic areas for Lilly to evaluate and profile. Participating organizations retain full IP rights to the compounds, but Lilly receives first rights to negotiate a broader collaboration or licensing agreement.

Clinical Data's PGx Health division will work with researchers at the university to discover and validate variants in the Fc gamma receptor genes, which they believe could potentially predict patient response to monoclonal antibody therapies.

IP Update: Apr 30, 2009

Premium

USPTO Publishes One Patent, Seven Patent Applications Related to RNAi

Patent Reform Act reintroduced; FDA clears UF-developed wound care tech; GSK inks ophthalmology research pact with University College London, and more ...

Cypress will pay up to $5 million for the technology, which it plans to use for diagnosis and therapeutic monitoring of lupus patients.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.